Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 36Neoplasms 17Breast Neoplasms 14Carcinoma, Non-Small-Cell Lung 6Polycystic Ovary Syndrome 4Lymphoma 4Lung Neoplasms 4Sarcopenia 3Prostatic Neoplasms 3Fatigue 3Colorectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Ovarian Neoplasms 2Obesity 2Malnutrition 2Lymphedema 2Insulin Resistance 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Weight Cycling 1Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1

Interventions

Carboplatin 4pertuzumab 2durvalumab 2Tretinoin 2Trastuzumab 2Standard of Care 2Paclitaxel 2Oxaliplatin 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1toripalimab 1tislelizumab 1talazoparib 1sarilumab 1relugolix 1regorafenib 1pexidartinib 1pembrolizumab 1patritumab 1olaparib 1niraparib 1nimotuzumab 1neratinib 1ganitumab 1enzalutamide 1dostarlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pathologic Complete Response × Exercise × Clear all
NCT07066189 2025-10-29

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

Yale University

Phase NA Recruiting
160 enrolled
Breast

Pathologic Complete Response, Motor Activity, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡